Jean Y. Blay

Lyon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

An evaluation of afamitresgene autoleucel for the treatment of advanced synovial sarcoma and myxoid round cell liposarcoma.

An evaluation of afamitresgene autoleucel for the treatment of advanced synovial sarcoma and myxoid round cell liposarcoma.

Journal: Expert review of anticancer therapy

Published: December 31, 2025

Sinonasal Sarcomas Management: An International Consensus Statement.

Sinonasal Sarcomas Management: An International Consensus Statement.

Journal: International forum of allergy & rhinology

Published: August 26, 2025

Chemotherapy-free cancer treatment - not for everyone yet.

Chemotherapy-free cancer treatment - not for everyone yet.

Journal: Trends in cancer

Published: July 01, 2025

Outcome of 1773 superficial non-dermatofibrosarcoma sarcomas A French Sarcoma Group study (FSG) from the NETSARC database.

Outcome of 1773 superficial non-dermatofibrosarcoma sarcomas A French Sarcoma Group study (FSG) from the NETSARC database.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 21, 2025

Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial.

Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial.

Journal: Nature medicine

Published: January 26, 2024

The French multicentric molecular analysis platforms and personalized medicine trials MOST, MOST Plus and MEGAMOST.

The French multicentric molecular analysis platforms and personalized medicine trials MOST, MOST Plus and MEGAMOST.

Journal: Acta oncologica (Stockholm, Sweden)

Published: November 30, 2023

Added value of whole-exome and RNA sequencing in advanced and refractory cancer patients with no molecular-based treatment recommendation based on a 90-gene panel.

Added value of whole-exome and RNA sequencing in advanced and refractory cancer patients with no molecular-based treatment recommendation based on a 90-gene panel.

Journal: Cancer medicine

Published: September 25, 2023

Evolution of Patterns of Care and Outcomes in the Real-Life Setting for Patients with Metastatic GIST Treated in Three French Expert Centers over Three Decades.

Evolution of Patterns of Care and Outcomes in the Real-Life Setting for Patients with Metastatic GIST Treated in Three French Expert Centers over Three Decades.

Journal: Cancers

Published: July 30, 2023

Initial Active Surveillance Strategy for Patients with Peripheral Sporadic Primary Desmoid-Type Fibromatosis: A Multicentric Phase II Observational Trial.

Initial Active Surveillance Strategy for Patients with Peripheral Sporadic Primary Desmoid-Type Fibromatosis: A Multicentric Phase II Observational Trial.

Journal: Annals of surgical oncology

Published: March 24, 2023

Uterine leiomyosarcoma - French guidelines from the GSF/NETSARC and TMRG groups

Uterine leiomyosarcoma - French guidelines from the GSF/NETSARC and TMRG groups

Journal: Bulletin du cancer

Published: September 29, 2022

Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study.

Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study.

Journal: Targeted oncology

Published: May 22, 2021

Vaccination against COVID-19 in patients with solid cancer: Review and point of view from a French oncology inter-group (CGO, TNCD, UNICANCER)

Vaccination against COVID-19 in patients with solid cancer: Review and point of view from a French oncology inter-group (CGO, TNCD, UNICANCER)

Journal: Bulletin du cancer

Published: February 05, 2021

Showing 1-12 of 39

Last Updated: 09/26/2026